Find, compare & contact
Valaciclovirum (Valaciclovir) API Manufacturers & Suppliers

Looking for Valaciclovir API 124832-26-4?

Description:

Here you will find a list of producers, manufacturers and distributors of Valaciclovir. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Valaciclovir 

Synonyms:

Valaciclovirum , Valacyclovir , Valaciclovir hydrochloride , hydrated , Valaciclovir hydrochloride  

Cas Number:

124832-26-4 

DrugBank number:

DB00577 

Unique Ingredient Identifier:

MZ1IW7Q79D

Valaciclovir is a type of Nucleoside and nucleotide analogs

Nucleoside and nucleotide analogs are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the development of antiviral and anticancer drugs. These compounds are structurally similar to natural nucleosides and nucleotides found in DNA and RNA, but they possess modified functional groups that enhance their therapeutic properties.

Nucleoside analogs are synthetic compounds composed of a nucleobase (adenine, cytosine, guanine, or thymine) and a sugar molecule, linked by a glycosidic bond. These analogs can act as competitive inhibitors of viral DNA or RNA synthesis by incorporating themselves into the growing nucleic acid chain, leading to premature termination of replication. This mechanism makes them effective against viral infections, including HIV, hepatitis B, and herpes.

On the other hand, nucleotide analogs are nucleoside analogs with an additional phosphate group attached to the sugar molecule. The presence of the phosphate group enhances their activity by providing an additional site for interaction with enzymes involved in nucleic acid synthesis. Nucleotide analogs are often used as prodrugs, requiring intracellular phosphorylation to become active. They have shown remarkable success in the treatment of certain types of cancer, particularly hematological malignancies.

The development and synthesis of nucleoside and nucleotide analogs require expertise in organic chemistry and medicinal chemistry. These compounds undergo rigorous testing to ensure their safety, efficacy, and compatibility with various drug formulations. The optimization of their pharmacokinetic and pharmacodynamic properties is a key focus during the drug development process.

In conclusion, nucleoside and nucleotide analogs are crucial components in the pharmaceutical industry's pursuit of effective antiviral and anticancer medications. Their unique structural modifications and mechanisms of action make them promising candidates for combating life-threatening diseases.

Valaciclovir (Nucleoside and nucleotide analogs), classified under Anti-infective Agents

Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.

Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.

The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.

The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.

In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.

• Xi'an Tian Guangyuan Biotech Co.,Ltd from China, product country of origin China
• Shandong Octagon Chemicals Limited from China, product country of origin China
• Sinoway industrial Co.,Ltd from China, product country of origin China
• Hikal from India, product country of origin India
• Shanghai Pharma Group from China, product country of origin China
• Osaka Synthetic Chemical Lab from Japan, product country of origin Japan
• Teva API from Israel, product country of origin Unknown
• Taizhou Highsun from China, product country of origin China
• Yung Zip Chemical from Taiwan, product country of origin Taiwan
• Hanmi Fine Chemical from South Korea, product country of origin South Korea
• Shanghai Group Changzhou Kony from China, product country of origin China
• Zhejiang Charioteer from China, product country of origin China
• Shanghai Acebright from China, product country of origin China
• Yichang Tianren Pharma from China, product country of origin China
• Hetero Drugs from India, product country of origin India
• Piramal Pharma Solutions from India, product country of origin India
• Shaoxing Hantai Pharma from China, product country of origin China
• Mylan from India, product country of origin India
• Lupin from India, product country of origin India
• Divis Labs. from India, product country of origin India
• Cipla from India, product country of origin India
• Sun Pharma from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.